Severity of abnormality influences decision to terminate pregnancies affected with fetal neural tube defects

Chris Grevengood, Lee P. Shulman, Jeffrey S. Dungan, Paula Martens, Owen Phillips, Donald S. Emerson, Richard E. Felker, Joe Leigh Simpson, Sherman Elias

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

We examined parental decision concerning pregnancy management in women having fetuses with neural tube defects (NTDs) to determine whether severity of defect or method of detection has an impact on the decision making process. Analysis of decisions by 50 women, whose pregnancies were affected by an isolated neural tube defect (NTD) and characterized by a singleton gestation at 24 gestational weeks or less with normal chromosomal complement (46, XX or 46, XY), were assessed. All 23 women carrying fetuses with anencephaly elected to terminate their pregnancies. Of the 27 women carrying fetuses with spina bifida, 21 (77.8%) elected to terminate their pregnancies and 6 (22.2%) elected to continue their pregnancies. Of the 6 pregnancies that were continued, 4 were initially detected by ultrasonography and 2 were ascertained by maternal serum α-fetoprotein screening; defects ranged from 2 to 14 vertebral bodies, and none of the defects were craniad to the T9 level. This is in comparison to 5 of the 21 spina bifida cases that were elective pregnancy terminations, which were characterized by fetal lesions craniad to the T9 level. Severity of NTD thus appears to influence the decision to continue or terminate an affected pregnancy.

Original languageEnglish (US)
Pages (from-to)273-277
Number of pages5
JournalFetal Diagnosis and Therapy
Volume9
Issue number4
DOIs
StatePublished - Jan 1 1994
Externally publishedYes

Fingerprint

Neural Tube Defects
Pregnancy
Spinal Dysraphism
Fetus
Fetal Proteins
Anencephaly
Decision Support Techniques
Ultrasonography
Decision Making
Mothers

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health
  • Embryology
  • Radiology Nuclear Medicine and imaging
  • Obstetrics and Gynecology

Cite this

Severity of abnormality influences decision to terminate pregnancies affected with fetal neural tube defects. / Grevengood, Chris; Shulman, Lee P.; Dungan, Jeffrey S.; Martens, Paula; Phillips, Owen; Emerson, Donald S.; Felker, Richard E.; Simpson, Joe Leigh; Elias, Sherman.

In: Fetal Diagnosis and Therapy, Vol. 9, No. 4, 01.01.1994, p. 273-277.

Research output: Contribution to journalArticle

Grevengood, C, Shulman, LP, Dungan, JS, Martens, P, Phillips, O, Emerson, DS, Felker, RE, Simpson, JL & Elias, S 1994, 'Severity of abnormality influences decision to terminate pregnancies affected with fetal neural tube defects', Fetal Diagnosis and Therapy, vol. 9, no. 4, pp. 273-277. https://doi.org/10.1159/000263947
Grevengood, Chris ; Shulman, Lee P. ; Dungan, Jeffrey S. ; Martens, Paula ; Phillips, Owen ; Emerson, Donald S. ; Felker, Richard E. ; Simpson, Joe Leigh ; Elias, Sherman. / Severity of abnormality influences decision to terminate pregnancies affected with fetal neural tube defects. In: Fetal Diagnosis and Therapy. 1994 ; Vol. 9, No. 4. pp. 273-277.
@article{95ec60f2ff884ab29a599e111202517e,
title = "Severity of abnormality influences decision to terminate pregnancies affected with fetal neural tube defects",
abstract = "We examined parental decision concerning pregnancy management in women having fetuses with neural tube defects (NTDs) to determine whether severity of defect or method of detection has an impact on the decision making process. Analysis of decisions by 50 women, whose pregnancies were affected by an isolated neural tube defect (NTD) and characterized by a singleton gestation at 24 gestational weeks or less with normal chromosomal complement (46, XX or 46, XY), were assessed. All 23 women carrying fetuses with anencephaly elected to terminate their pregnancies. Of the 27 women carrying fetuses with spina bifida, 21 (77.8{\%}) elected to terminate their pregnancies and 6 (22.2{\%}) elected to continue their pregnancies. Of the 6 pregnancies that were continued, 4 were initially detected by ultrasonography and 2 were ascertained by maternal serum α-fetoprotein screening; defects ranged from 2 to 14 vertebral bodies, and none of the defects were craniad to the T9 level. This is in comparison to 5 of the 21 spina bifida cases that were elective pregnancy terminations, which were characterized by fetal lesions craniad to the T9 level. Severity of NTD thus appears to influence the decision to continue or terminate an affected pregnancy.",
author = "Chris Grevengood and Shulman, {Lee P.} and Dungan, {Jeffrey S.} and Paula Martens and Owen Phillips and Emerson, {Donald S.} and Felker, {Richard E.} and Simpson, {Joe Leigh} and Sherman Elias",
year = "1994",
month = "1",
day = "1",
doi = "10.1159/000263947",
language = "English (US)",
volume = "9",
pages = "273--277",
journal = "Fetal Diagnosis and Therapy",
issn = "1015-3837",
publisher = "S. Karger AG",
number = "4",

}

TY - JOUR

T1 - Severity of abnormality influences decision to terminate pregnancies affected with fetal neural tube defects

AU - Grevengood, Chris

AU - Shulman, Lee P.

AU - Dungan, Jeffrey S.

AU - Martens, Paula

AU - Phillips, Owen

AU - Emerson, Donald S.

AU - Felker, Richard E.

AU - Simpson, Joe Leigh

AU - Elias, Sherman

PY - 1994/1/1

Y1 - 1994/1/1

N2 - We examined parental decision concerning pregnancy management in women having fetuses with neural tube defects (NTDs) to determine whether severity of defect or method of detection has an impact on the decision making process. Analysis of decisions by 50 women, whose pregnancies were affected by an isolated neural tube defect (NTD) and characterized by a singleton gestation at 24 gestational weeks or less with normal chromosomal complement (46, XX or 46, XY), were assessed. All 23 women carrying fetuses with anencephaly elected to terminate their pregnancies. Of the 27 women carrying fetuses with spina bifida, 21 (77.8%) elected to terminate their pregnancies and 6 (22.2%) elected to continue their pregnancies. Of the 6 pregnancies that were continued, 4 were initially detected by ultrasonography and 2 were ascertained by maternal serum α-fetoprotein screening; defects ranged from 2 to 14 vertebral bodies, and none of the defects were craniad to the T9 level. This is in comparison to 5 of the 21 spina bifida cases that were elective pregnancy terminations, which were characterized by fetal lesions craniad to the T9 level. Severity of NTD thus appears to influence the decision to continue or terminate an affected pregnancy.

AB - We examined parental decision concerning pregnancy management in women having fetuses with neural tube defects (NTDs) to determine whether severity of defect or method of detection has an impact on the decision making process. Analysis of decisions by 50 women, whose pregnancies were affected by an isolated neural tube defect (NTD) and characterized by a singleton gestation at 24 gestational weeks or less with normal chromosomal complement (46, XX or 46, XY), were assessed. All 23 women carrying fetuses with anencephaly elected to terminate their pregnancies. Of the 27 women carrying fetuses with spina bifida, 21 (77.8%) elected to terminate their pregnancies and 6 (22.2%) elected to continue their pregnancies. Of the 6 pregnancies that were continued, 4 were initially detected by ultrasonography and 2 were ascertained by maternal serum α-fetoprotein screening; defects ranged from 2 to 14 vertebral bodies, and none of the defects were craniad to the T9 level. This is in comparison to 5 of the 21 spina bifida cases that were elective pregnancy terminations, which were characterized by fetal lesions craniad to the T9 level. Severity of NTD thus appears to influence the decision to continue or terminate an affected pregnancy.

UR - http://www.scopus.com/inward/record.url?scp=0028110966&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028110966&partnerID=8YFLogxK

U2 - 10.1159/000263947

DO - 10.1159/000263947

M3 - Article

C2 - 7524525

AN - SCOPUS:0028110966

VL - 9

SP - 273

EP - 277

JO - Fetal Diagnosis and Therapy

JF - Fetal Diagnosis and Therapy

SN - 1015-3837

IS - 4

ER -